Lion Street Advisors’s Idexx Laboratories IDXX Stock Holding History

Lion Street Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-690	Closed	-$302K	–	256
2023 Q3	$302K	Buy	690 +255	+59%	+$127K	0.1%	181
2023 Q2	$290K	Buy	+435	New	+$208K	0.1%	172
2023 Q1	–	Sell	-433	Closed	-$288K	–	253
2022 Q4	$288K	Buy	+433	New	+$168K	0.15%	111
2022 Q3	–	Sell	-433	Closed	-$293K	–	149
2022 Q2	$293K	Buy	+433	New	+$177K	0.15%	110
2022 Q1	–	Sell	-430	Closed	-$288K	–	154
2021 Q4	$288K	Sell	430 -3	-0.7%	-$1.88K	0.14%	112
2021 Q3	$273K	Buy	+433	New	+$291K	0.15%	111
2020 Q2	–	Sell	-15	Closed	-$4K	–	204
2020 Q1	$4K	Buy	+15	New	+$3.92K	0.02%	286

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Lion Street Advisors's IDXX Position: Q4 2023 in Review

Lion Street Advisors sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 690 shares — an estimated $302K sold.

Lion Street Advisors first reported a position in IDXX in Q1 2020 and held it in 7 quarters. The position peaked at $302K in Q3 2023. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

Lion Street Advisors reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
Lion Street Advisors sold 690 Idexx Laboratories shares in Q4 2023, an estimated $302K.
Lion Street Advisors first reported a position in Idexx Laboratories in Q1 2020 and held it in 7 quarters.
Lion Street Advisors's Idexx Laboratories position peaked at $302K in Q3 2023.
1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Lion Street Advisors's 13F filing for Q4 2023, filed 10 Jan 2024.